200 related articles for article (PubMed ID: 21545756)
21. Intellectual and Behavioral Phenotypes of Smith-Magenis Syndrome: Comparisons between Individuals with a 17p11.2 Deletion and Pathogenic
Linders CC; van Eeghen AM; Zinkstok JR; van den Boogaard MJ; Boot E
Genes (Basel); 2023 Jul; 14(8):. PubMed ID: 37628566
[TBL] [Abstract][Full Text] [Related]
22. Temporal dissection of Rai1 function reveals brain-derived neurotrophic factor as a potential therapeutic target for Smith-Magenis syndrome.
Javed S; Lee YJ; Xu J; Huang WH
Hum Mol Genet; 2021 Dec; 31(2):275-288. PubMed ID: 34463714
[TBL] [Abstract][Full Text] [Related]
23. Identification of Nine New RAI1-Truncating Mutations in Smith-Magenis Syndrome Patients without 17p11.2 Deletions.
Dubourg C; Bonnet-Brilhault F; Toutain A; Mignot C; Jacquette A; Dieux A; Gérard M; Beaumont-Epinette MP; Julia S; Isidor B; Rossi M; Odent S; Bendavid C; Barthélémy C; Verloes A; David V
Mol Syndromol; 2014 Feb; 5(2):57-64. PubMed ID: 24715852
[TBL] [Abstract][Full Text] [Related]
24. Management of Sleep Disturbances Associated with Smith-Magenis Syndrome.
Kaplan KA; Elsea SH; Potocki L
CNS Drugs; 2020 Jul; 34(7):723-730. PubMed ID: 32495322
[TBL] [Abstract][Full Text] [Related]
25. Circadian abnormalities in mouse models of Smith-Magenis syndrome: evidence for involvement of RAI1.
Lacaria M; Gu W; Lupski JR
Am J Med Genet A; 2013 Jul; 161A(7):1561-8. PubMed ID: 23703963
[TBL] [Abstract][Full Text] [Related]
26. Psychiatric and neurological manifestations in adults with Smith-Magenis syndrome: A scoping review.
Korteling D; Musch JLI; Zinkstok JR; Boot E
Am J Med Genet B Neuropsychiatr Genet; 2024 Mar; 195(2):e32956. PubMed ID: 37584268
[TBL] [Abstract][Full Text] [Related]
27. Molecular and Neural Functions of Rai1, the Causal Gene for Smith-Magenis Syndrome.
Huang WH; Guenthner CJ; Xu J; Nguyen T; Schwarz LA; Wilkinson AW; Gozani O; Chang HY; Shamloo M; Luo L
Neuron; 2016 Oct; 92(2):392-406. PubMed ID: 27693255
[TBL] [Abstract][Full Text] [Related]
28. Smith-Magenis syndrome and its circadian influence on development, behavior, and obesity - own experience.
Chen L; Mullegama SV; Alaimo JT; Elsea SH
Dev Period Med; 2015; 19(2):149-56. PubMed ID: 26384114
[TBL] [Abstract][Full Text] [Related]
29. Production and characterization of CSSI003 (2961) human induced pluripotent stem cells (iPSCs) carrying a novel puntiform mutation in RAI1 gene, Causative of Smith-Magenis syndrome.
Altieri F; Turco EM; Vinci E; Torres B; Ferrari D; De Jaco A; Mazzoccoli G; Lamorte G; Nardone A; Della Monica M; Bernardini L; Vescovi AL; Rosati J
Stem Cell Res; 2018 Apr; 28():153-156. PubMed ID: 29494847
[TBL] [Abstract][Full Text] [Related]
30. Mutations of RAI1, a PHD-containing protein, in nondeletion patients with Smith-Magenis syndrome.
Bi W; Saifi GM; Shaw CJ; Walz K; Fonseca P; Wilson M; Potocki L; Lupski JR
Hum Genet; 2004 Nov; 115(6):515-24. PubMed ID: 15565467
[TBL] [Abstract][Full Text] [Related]
31. RAI1 point mutations, CAG repeat variation, and SNP analysis in non-deletion Smith-Magenis syndrome.
Bi W; Saifi GM; Girirajan S; Shi X; Szomju B; Firth H; Magenis RE; Potocki L; Elsea SH; Lupski JR
Am J Med Genet A; 2006 Nov; 140(22):2454-63. PubMed ID: 17041942
[TBL] [Abstract][Full Text] [Related]
32. Identification of a RAI1-associated disease network through integration of exome sequencing, transcriptomics, and 3D genomics.
Loviglio MN; Beck CR; White JJ; Leleu M; Harel T; Guex N; Niknejad A; Bi W; Chen ES; Crespo I; Yan J; Charng WL; Gu S; Fang P; Coban-Akdemir Z; Shaw CA; Jhangiani SN; Muzny DM; Gibbs RA; Rougemont J; Xenarios I; Lupski JR; Reymond A
Genome Med; 2016 Nov; 8(1):105. PubMed ID: 27799067
[TBL] [Abstract][Full Text] [Related]
33.
Falco M; Amabile S; Acquaviva F
Appl Clin Genet; 2017; 10():85-94. PubMed ID: 29138588
[TBL] [Abstract][Full Text] [Related]
34. Evidence for genetic regulation of mRNA expression of the dosage-sensitive gene retinoic acid induced-1 (RAI1) in human brain.
Chen L; Tao Y; Song F; Yuan X; Wang J; Saffen D
Sci Rep; 2016 Jan; 6():19010. PubMed ID: 26743651
[TBL] [Abstract][Full Text] [Related]
35. Functional and cellular characterization of human Retinoic Acid Induced 1 (RAI1) mutations associated with Smith-Magenis Syndrome.
Carmona-Mora P; Encina CA; Canales CP; Cao L; Molina J; Kairath P; Young JI; Walz K
BMC Mol Biol; 2010 Aug; 11():63. PubMed ID: 20738874
[TBL] [Abstract][Full Text] [Related]
36. Reciprocal deletion and duplication of 17p11.2-11.2: Korean patients with Smith-Magenis syndrome and Potocki-Lupski syndrome.
Lee CG; Park SJ; Yun JN; Yim SY; Sohn YB
J Korean Med Sci; 2012 Dec; 27(12):1586-90. PubMed ID: 23255863
[TBL] [Abstract][Full Text] [Related]
37. Dietary regimens modify early onset of obesity in mice haploinsufficient for Rai1.
Alaimo JT; Hahn NC; Mullegama SV; Elsea SH
PLoS One; 2014; 9(8):e105077. PubMed ID: 25127133
[TBL] [Abstract][Full Text] [Related]
38. Twenty-four-hour motor activity and body temperature patterns suggest altered central circadian timekeeping in Smith-Magenis syndrome, a neurodevelopmental disorder.
Smith ACM; Morse RS; Introne W; Duncan WC
Am J Med Genet A; 2019 Feb; 179(2):224-236. PubMed ID: 30690916
[TBL] [Abstract][Full Text] [Related]
39. A duplication CNV that conveys traits reciprocal to metabolic syndrome and protects against diet-induced obesity in mice and men.
Lacaria M; Saha P; Potocki L; Bi W; Yan J; Girirajan S; Burns B; Elsea S; Walz K; Chan L; Lupski JR; Gu W
PLoS Genet; 2012; 8(5):e1002713. PubMed ID: 22654670
[TBL] [Abstract][Full Text] [Related]
40. Inactivation of Rai1 in mice recapitulates phenotypes observed in chromosome engineered mouse models for Smith-Magenis syndrome.
Bi W; Ohyama T; Nakamura H; Yan J; Visvanathan J; Justice MJ; Lupski JR
Hum Mol Genet; 2005 Apr; 14(8):983-95. PubMed ID: 15746153
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
